E

Enlivex Therapeutics Ltd
D

ENLV

4.56000
USD
0.03
(0.66%)
مغلق
حجم التداول
1,355
الربح لكل سهم
-1
العائد الربحي
-
P/E
0
حجم السوق
76,753,988
أصول ذات صلة المقالات
المزيد

العنوان: Enlivex Ltd

القطاع: Healthcare
الصناعة: Biotechnology
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.